nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.319	0.521	CiPCiCtD
Itraconazole—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.293	0.479	CiPCiCtD
Itraconazole—CYP1A1—Clobetasol propionate—psoriasis	0.0423	0.153	CbGbCtD
Itraconazole—CYP1A1—Methoxsalen—psoriasis	0.0222	0.0804	CbGbCtD
Itraconazole—CYP3A5—Beclomethasone—psoriasis	0.0193	0.0696	CbGbCtD
Itraconazole—CYP1A1—Cholecalciferol—psoriasis	0.0147	0.0533	CbGbCtD
Itraconazole—CYP2B6—Cholecalciferol—psoriasis	0.0112	0.0406	CbGbCtD
Itraconazole—CYP2D6—Hydroxyurea—psoriasis	0.00895	0.0324	CbGbCtD
Itraconazole—CYP3A7—Hydrocortisone—psoriasis	0.0082	0.0297	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0082	0.0297	CbGbCtD
Itraconazole—CYP3A7—Cyclosporine—psoriasis	0.00774	0.028	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00774	0.028	CbGbCtD
Itraconazole—CYP3A5—Mycophenolate mofetil—psoriasis	0.00767	0.0277	CbGbCtD
Itraconazole—CYP3A4—Calcitriol—psoriasis	0.00669	0.0242	CbGbCtD
Itraconazole—CYP1A1—Dexamethasone—psoriasis	0.00637	0.023	CbGbCtD
Itraconazole—CYP3A5—Hydrocortisone—psoriasis	0.00615	0.0222	CbGbCtD
Itraconazole—CYP3A5—Cyclosporine—psoriasis	0.00581	0.021	CbGbCtD
Itraconazole—CYP2D6—Cholecalciferol—psoriasis	0.00542	0.0196	CbGbCtD
Itraconazole—CYP3A4—Methoxsalen—psoriasis	0.0052	0.0188	CbGbCtD
Itraconazole—CYP3A7—Dexamethasone—psoriasis	0.0051	0.0184	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0051	0.0184	CbGbCtD
Itraconazole—ABCB1—Mycophenolate mofetil—psoriasis	0.00499	0.018	CbGbCtD
Itraconazole—CYP2E1—Dexamethasone—psoriasis	0.00492	0.0178	CbGbCtD
Itraconazole—CYP2B6—Dexamethasone—psoriasis	0.00486	0.0176	CbGbCtD
Itraconazole—ABCB1—Betamethasone—psoriasis	0.00428	0.0155	CbGbCtD
Itraconazole—ABCB1—Prednisolone—psoriasis	0.00422	0.0153	CbGbCtD
Itraconazole—ABCB1—Hydrocortisone—psoriasis	0.004	0.0145	CbGbCtD
Itraconazole—ABCB1—Prednisone—psoriasis	0.00399	0.0144	CbGbCtD
Itraconazole—CYP3A5—Dexamethasone—psoriasis	0.00383	0.0138	CbGbCtD
Itraconazole—ABCB1—Cyclosporine—psoriasis	0.00378	0.0137	CbGbCtD
Itraconazole—CYP2D6—Cyclosporine—psoriasis	0.00356	0.0129	CbGbCtD
Itraconazole—CYP3A4—Cholecalciferol—psoriasis	0.00345	0.0125	CbGbCtD
Itraconazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00299	0.0108	CbGbCtD
Itraconazole—CYP3A4—Triamcinolone—psoriasis	0.00299	0.0108	CbGbCtD
Itraconazole—CYP3A4—Betamethasone—psoriasis	0.00256	0.00927	CbGbCtD
Itraconazole—CYP3A4—Prednisolone—psoriasis	0.00253	0.00915	CbGbCtD
Itraconazole—ABCB1—Dexamethasone—psoriasis	0.00249	0.009	CbGbCtD
Itraconazole—CYP3A4—Hydrocortisone—psoriasis	0.0024	0.00867	CbGbCtD
Itraconazole—CYP3A4—Prednisone—psoriasis	0.00239	0.00864	CbGbCtD
Itraconazole—CYP2D6—Dexamethasone—psoriasis	0.00235	0.00848	CbGbCtD
Itraconazole—CYP3A4—Cyclosporine—psoriasis	0.00227	0.00819	CbGbCtD
Itraconazole—ABCB1—Methotrexate—psoriasis	0.002	0.00724	CbGbCtD
Itraconazole—CYP3A4—Dexamethasone—psoriasis	0.00149	0.00539	CbGbCtD
Itraconazole—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00081	0.0459	CbGpPWpGaD
Itraconazole—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.000793	0.045	CbGpPWpGaD
Itraconazole—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.000679	0.0385	CbGpPWpGaD
Itraconazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00063	0.0357	CbGpPWpGaD
Itraconazole—CYP51A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000622	0.0353	CbGpPWpGaD
Itraconazole—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000563	0.0319	CbGpPWpGaD
Itraconazole—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000525	0.0298	CbGpPWpGaD
Itraconazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000511	0.029	CbGpPWpGaD
Itraconazole—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000502	0.0285	CbGpPWpGaD
Itraconazole—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.000492	0.0279	CbGpPWpGaD
Itraconazole—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000491	0.0278	CbGpPWpGaD
Itraconazole—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.000464	0.0263	CbGpPWpGaD
Itraconazole—CYP51A1—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.000426	0.0241	CbGpPWpGaD
Itraconazole—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000349	0.0198	CbGpPWpGaD
Itraconazole—CYP51A1—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00034	0.0193	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL22—psoriasis	0.000297	0.0169	CbGpPWpGaD
Itraconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000282	0.016	CbGpPWpGaD
Itraconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000278	0.0158	CbGpPWpGaD
Itraconazole—CYP51A1—Biological oxidations—CYP2S1—psoriasis	0.000271	0.0154	CbGpPWpGaD
Itraconazole—CYP51A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000268	0.0152	CbGpPWpGaD
Itraconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000228	0.013	CbGpPWpGaD
Itraconazole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000228	0.0129	CbGpPWpGaD
Itraconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000208	0.0118	CbGpPWpGaD
Itraconazole—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000206	0.0117	CbGpPWpGaD
Itraconazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000204	0.0116	CbGpPWpGaD
Itraconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000204	0.0116	CbGpPWpGaD
Itraconazole—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000201	0.0114	CbGpPWpGaD
Itraconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000201	0.0114	CbGpPWpGaD
Itraconazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000192	0.0109	CbGpPWpGaD
Itraconazole—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00019	0.0108	CbGpPWpGaD
Itraconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000169	0.00959	CbGpPWpGaD
Itraconazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000166	0.00939	CbGpPWpGaD
Itraconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000165	0.00937	CbGpPWpGaD
Itraconazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000156	0.00885	CbGpPWpGaD
Itraconazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000145	0.00822	CbGpPWpGaD
Itraconazole—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000143	0.00811	CbGpPWpGaD
Itraconazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000123	0.00698	CbGpPWpGaD
Itraconazole—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000121	0.00689	CbGpPWpGaD
Itraconazole—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.00012	0.00679	CbGpPWpGaD
Itraconazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000117	0.00666	CbGpPWpGaD
Itraconazole—CYP51A1—SREBP signalling—PPARG—psoriasis	0.000115	0.0065	CbGpPWpGaD
Itraconazole—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000101	0.00571	CbGpPWpGaD
Itraconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.57e-05	0.00543	CbGpPWpGaD
Itraconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.47e-05	0.00537	CbGpPWpGaD
Itraconazole—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	9.43e-05	0.00535	CbGpPWpGaD
Itraconazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.38e-05	0.00532	CbGpPWpGaD
Itraconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.35e-05	0.0053	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.24e-05	0.00524	CbGpPWpGaD
Itraconazole—CYP2B6—Biological oxidations—CYP2S1—psoriasis	8.98e-05	0.00509	CbGpPWpGaD
Itraconazole—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	8.85e-05	0.00502	CbGpPWpGaD
Itraconazole—CYP2E1—Biological oxidations—CYP2S1—psoriasis	8.79e-05	0.00499	CbGpPWpGaD
Itraconazole—CYP3A5—Biological oxidations—CYP2S1—psoriasis	8.77e-05	0.00498	CbGpPWpGaD
Itraconazole—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	8.67e-05	0.00492	CbGpPWpGaD
Itraconazole—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	8.65e-05	0.00491	CbGpPWpGaD
Itraconazole—CYP1A1—Biological oxidations—CYP2S1—psoriasis	8.29e-05	0.0047	CbGpPWpGaD
Itraconazole—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	8.17e-05	0.00464	CbGpPWpGaD
Itraconazole—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	8.16e-05	0.00463	CbGpPWpGaD
Itraconazole—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	8.04e-05	0.00456	CbGpPWpGaD
Itraconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.68e-05	0.00436	CbGpPWpGaD
Itraconazole—CYP2E1—Tryptophan metabolism—CAT—psoriasis	7.58e-05	0.0043	CbGpPWpGaD
Itraconazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	7.57e-05	0.0043	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	7.29e-05	0.00414	CbGpPWpGaD
Itraconazole—CYP1A1—Tryptophan metabolism—CAT—psoriasis	7.15e-05	0.00406	CbGpPWpGaD
Itraconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.06e-05	0.00401	CbGpPWpGaD
Itraconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.67e-05	0.00379	CbGpPWpGaD
Itraconazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.54e-05	0.00371	CbGpPWpGaD
Itraconazole—CYP2D6—Biological oxidations—CYP2S1—psoriasis	6.24e-05	0.00354	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	6.15e-05	0.00349	CbGpPWpGaD
Itraconazole—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	6.05e-05	0.00343	CbGpPWpGaD
Itraconazole—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	5.79e-05	0.00328	CbGpPWpGaD
Itraconazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	5.66e-05	0.00321	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—HLA-C—psoriasis	5.63e-05	0.00319	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL13—psoriasis	5.59e-05	0.00317	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—NDUFA5—psoriasis	5.46e-05	0.0031	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL17A—psoriasis	5.15e-05	0.00292	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.09e-05	0.00289	CbGpPWpGaD
Itraconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.92e-05	0.00279	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL12B—psoriasis	4.79e-05	0.00272	CbGpPWpGaD
Itraconazole—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	4.78e-05	0.00271	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.67e-05	0.00265	CbGpPWpGaD
Itraconazole—CYP1A1—Oxidative Stress—NFKB1—psoriasis	4.65e-05	0.00264	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—CYP2S1—psoriasis	4.64e-05	0.00263	CbGpPWpGaD
Itraconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.35e-05	0.00247	CbGpPWpGaD
Itraconazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.08e-05	0.00231	CbGpPWpGaD
Itraconazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.02e-05	0.00228	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.97e-05	0.00225	CbGpPWpGaD
Itraconazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	3.9e-05	0.00221	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.87e-05	0.00219	CbGpPWpGaD
Itraconazole—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.6e-05	0.00204	CbGpPWpGaD
Itraconazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.52e-05	0.002	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL10—psoriasis	3.5e-05	0.00199	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.43e-05	0.00195	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—IL4—psoriasis	3.4e-05	0.00193	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—HLA-B—psoriasis	3.33e-05	0.00189	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.32e-05	0.00189	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.3e-05	0.00187	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.1e-05	0.00176	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.08e-05	0.00175	CbGpPWpGaD
Itraconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.03e-05	0.00172	CbGpPWpGaD
Itraconazole—Anxiety—Betamethasone—psoriasis	3.02e-05	0.000323	CcSEcCtD
Itraconazole—Vomiting—Mycophenolic acid—psoriasis	3.01e-05	0.000322	CcSEcCtD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3e-05	0.0017	CbGpPWpGaD
Itraconazole—Discomfort—Betamethasone—psoriasis	2.99e-05	0.00032	CcSEcCtD
Itraconazole—Discomfort—Dexamethasone—psoriasis	2.99e-05	0.00032	CcSEcCtD
Itraconazole—Dyspepsia—Hydrocortisone—psoriasis	2.99e-05	0.00032	CcSEcCtD
Itraconazole—Rash—Mycophenolic acid—psoriasis	2.98e-05	0.000319	CcSEcCtD
Itraconazole—Dermatitis—Mycophenolic acid—psoriasis	2.98e-05	0.000319	CcSEcCtD
Itraconazole—Pain—Prednisolone—psoriasis	2.98e-05	0.000319	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—psoriasis	2.97e-05	0.000318	CcSEcCtD
Itraconazole—Urticaria—Mycophenolate mofetil—psoriasis	2.96e-05	0.000317	CcSEcCtD
Itraconazole—Headache—Mycophenolic acid—psoriasis	2.96e-05	0.000317	CcSEcCtD
Itraconazole—Decreased appetite—Hydrocortisone—psoriasis	2.95e-05	0.000316	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—psoriasis	2.95e-05	0.000316	CcSEcCtD
Itraconazole—Body temperature increased—Mycophenolate mofetil—psoriasis	2.95e-05	0.000316	CcSEcCtD
Itraconazole—Abdominal pain—Mycophenolate mofetil—psoriasis	2.95e-05	0.000316	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—psoriasis	2.94e-05	0.000315	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.93e-05	0.000314	CcSEcCtD
Itraconazole—Fatigue—Hydrocortisone—psoriasis	2.93e-05	0.000314	CcSEcCtD
Itraconazole—Vision blurred—Prednisone—psoriasis	2.92e-05	0.000313	CcSEcCtD
Itraconazole—Urethral disorder—Methotrexate—psoriasis	2.92e-05	0.000312	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.92e-05	0.000312	CcSEcCtD
Itraconazole—Pain—Hydrocortisone—psoriasis	2.91e-05	0.000311	CcSEcCtD
Itraconazole—Oedema—Betamethasone—psoriasis	2.9e-05	0.000311	CcSEcCtD
Itraconazole—Anaphylactic shock—Dexamethasone—psoriasis	2.9e-05	0.000311	CcSEcCtD
Itraconazole—Anaphylactic shock—Betamethasone—psoriasis	2.9e-05	0.000311	CcSEcCtD
Itraconazole—Oedema—Dexamethasone—psoriasis	2.9e-05	0.000311	CcSEcCtD
Itraconazole—Insomnia—Triamcinolone—psoriasis	2.89e-05	0.00031	CcSEcCtD
Itraconazole—Infection—Betamethasone—psoriasis	2.88e-05	0.000309	CcSEcCtD
Itraconazole—Infection—Dexamethasone—psoriasis	2.88e-05	0.000309	CcSEcCtD
Itraconazole—Ill-defined disorder—Prednisone—psoriasis	2.87e-05	0.000308	CcSEcCtD
Itraconazole—Paraesthesia—Triamcinolone—psoriasis	2.87e-05	0.000308	CcSEcCtD
Itraconazole—Feeling abnormal—Prednisolone—psoriasis	2.87e-05	0.000307	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—psoriasis	2.87e-05	0.000307	CcSEcCtD
Itraconazole—Shock—Dexamethasone—psoriasis	2.86e-05	0.000306	CcSEcCtD
Itraconazole—Shock—Betamethasone—psoriasis	2.86e-05	0.000306	CcSEcCtD
Itraconazole—Dyspnoea—Triamcinolone—psoriasis	2.85e-05	0.000305	CcSEcCtD
Itraconazole—Nervous system disorder—Betamethasone—psoriasis	2.85e-05	0.000305	CcSEcCtD
Itraconazole—Nervous system disorder—Dexamethasone—psoriasis	2.85e-05	0.000305	CcSEcCtD
Itraconazole—Thrombocytopenia—Dexamethasone—psoriasis	2.84e-05	0.000304	CcSEcCtD
Itraconazole—Thrombocytopenia—Betamethasone—psoriasis	2.84e-05	0.000304	CcSEcCtD
Itraconazole—Tachycardia—Dexamethasone—psoriasis	2.83e-05	0.000303	CcSEcCtD
Itraconazole—Tachycardia—Betamethasone—psoriasis	2.83e-05	0.000303	CcSEcCtD
Itraconazole—Angioedema—Prednisone—psoriasis	2.83e-05	0.000303	CcSEcCtD
Itraconazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.82e-05	0.0016	CbGpPWpGaD
Itraconazole—Hypersensitivity—Cyclosporine—psoriasis	2.82e-05	0.000302	CcSEcCtD
Itraconazole—Dyspepsia—Triamcinolone—psoriasis	2.82e-05	0.000302	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—psoriasis	2.81e-05	0.000301	CcSEcCtD
Itraconazole—Nausea—Mycophenolic acid—psoriasis	2.81e-05	0.000301	CcSEcCtD
Itraconazole—Hyperhidrosis—Dexamethasone—psoriasis	2.81e-05	0.000301	CcSEcCtD
Itraconazole—Hyperhidrosis—Betamethasone—psoriasis	2.81e-05	0.000301	CcSEcCtD
Itraconazole—Feeling abnormal—Hydrocortisone—psoriasis	2.8e-05	0.0003	CcSEcCtD
Itraconazole—Malaise—Prednisone—psoriasis	2.79e-05	0.000299	CcSEcCtD
Itraconazole—Vertigo—Prednisone—psoriasis	2.78e-05	0.000298	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—psoriasis	2.78e-05	0.000298	CcSEcCtD
Itraconazole—Gastrointestinal pain—Hydrocortisone—psoriasis	2.78e-05	0.000298	CcSEcCtD
Itraconazole—Syncope—Prednisone—psoriasis	2.78e-05	0.000297	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—psoriasis	2.77e-05	0.000297	CcSEcCtD
Itraconazole—Anorexia—Betamethasone—psoriasis	2.77e-05	0.000296	CcSEcCtD
Itraconazole—Anorexia—Dexamethasone—psoriasis	2.77e-05	0.000296	CcSEcCtD
Itraconazole—Urticaria—Prednisolone—psoriasis	2.76e-05	0.000296	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—psoriasis	2.76e-05	0.000296	CcSEcCtD
Itraconazole—Fatigue—Triamcinolone—psoriasis	2.76e-05	0.000295	CcSEcCtD
Itraconazole—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.75e-05	0.000294	CcSEcCtD
Itraconazole—Asthenia—Cyclosporine—psoriasis	2.74e-05	0.000294	CcSEcCtD
Itraconazole—Pain—Triamcinolone—psoriasis	2.74e-05	0.000293	CcSEcCtD
Itraconazole—Loss of consciousness—Prednisone—psoriasis	2.72e-05	0.000292	CcSEcCtD
Itraconazole—Hypotension—Betamethasone—psoriasis	2.71e-05	0.000291	CcSEcCtD
Itraconazole—Hypotension—Dexamethasone—psoriasis	2.71e-05	0.000291	CcSEcCtD
Itraconazole—Pruritus—Cyclosporine—psoriasis	2.71e-05	0.00029	CcSEcCtD
Itraconazole—Urticaria—Hydrocortisone—psoriasis	2.7e-05	0.000289	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—psoriasis	2.7e-05	0.000289	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—psoriasis	2.69e-05	0.000288	CcSEcCtD
Itraconazole—Abdominal pain—Hydrocortisone—psoriasis	2.69e-05	0.000288	CcSEcCtD
Itraconazole—Body temperature increased—Hydrocortisone—psoriasis	2.69e-05	0.000288	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—psoriasis	2.68e-05	0.000287	CcSEcCtD
Itraconazole—Asthenia—Mycophenolate mofetil—psoriasis	2.68e-05	0.000287	CcSEcCtD
Itraconazole—Hypertension—Prednisone—psoriasis	2.67e-05	0.000286	CcSEcCtD
Itraconazole—Chills—Methotrexate—psoriasis	2.67e-05	0.000286	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.65e-05	0.000283	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Betamethasone—psoriasis	2.65e-05	0.000283	CcSEcCtD
Itraconazole—Pruritus—Mycophenolate mofetil—psoriasis	2.64e-05	0.000283	CcSEcCtD
Itraconazole—Myalgia—Prednisone—psoriasis	2.64e-05	0.000282	CcSEcCtD
Itraconazole—Arthralgia—Prednisone—psoriasis	2.64e-05	0.000282	CcSEcCtD
Itraconazole—Feeling abnormal—Triamcinolone—psoriasis	2.64e-05	0.000282	CcSEcCtD
Itraconazole—Anxiety—Prednisone—psoriasis	2.63e-05	0.000281	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—psoriasis	2.63e-05	0.000281	CcSEcCtD
Itraconazole—Insomnia—Betamethasone—psoriasis	2.63e-05	0.000281	CcSEcCtD
Itraconazole—Insomnia—Dexamethasone—psoriasis	2.63e-05	0.000281	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.62e-05	0.00028	CcSEcCtD
Itraconazole—Diarrhoea—Cyclosporine—psoriasis	2.62e-05	0.00028	CcSEcCtD
Itraconazole—Paraesthesia—Dexamethasone—psoriasis	2.61e-05	0.000279	CcSEcCtD
Itraconazole—Paraesthesia—Betamethasone—psoriasis	2.61e-05	0.000279	CcSEcCtD
Itraconazole—Discomfort—Prednisone—psoriasis	2.61e-05	0.000279	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—psoriasis	2.61e-05	0.000279	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—psoriasis	2.59e-05	0.000277	CcSEcCtD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.57e-05	0.00146	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.57e-05	0.00146	CbGpPWpGaD
Itraconazole—Hypersensitivity—Prednisolone—psoriasis	2.56e-05	0.000275	CcSEcCtD
Itraconazole—Dyspepsia—Dexamethasone—psoriasis	2.56e-05	0.000274	CcSEcCtD
Itraconazole—Dyspepsia—Betamethasone—psoriasis	2.56e-05	0.000274	CcSEcCtD
Itraconazole—Diarrhoea—Mycophenolate mofetil—psoriasis	2.55e-05	0.000273	CcSEcCtD
Itraconazole—Urticaria—Triamcinolone—psoriasis	2.54e-05	0.000272	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—psoriasis	2.54e-05	0.000271	CcSEcCtD
Itraconazole—Body temperature increased—Triamcinolone—psoriasis	2.53e-05	0.000271	CcSEcCtD
Itraconazole—Dizziness—Cyclosporine—psoriasis	2.53e-05	0.000271	CcSEcCtD
Itraconazole—Oedema—Prednisone—psoriasis	2.53e-05	0.000271	CcSEcCtD
Itraconazole—Anaphylactic shock—Prednisone—psoriasis	2.53e-05	0.000271	CcSEcCtD
Itraconazole—Decreased appetite—Dexamethasone—psoriasis	2.52e-05	0.00027	CcSEcCtD
Itraconazole—Decreased appetite—Betamethasone—psoriasis	2.52e-05	0.00027	CcSEcCtD
Itraconazole—Infection—Prednisone—psoriasis	2.51e-05	0.000269	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Betamethasone—psoriasis	2.51e-05	0.000268	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Dexamethasone—psoriasis	2.51e-05	0.000268	CcSEcCtD
Itraconazole—Back pain—Methotrexate—psoriasis	2.5e-05	0.000268	CcSEcCtD
Itraconazole—Hypersensitivity—Hydrocortisone—psoriasis	2.5e-05	0.000268	CcSEcCtD
Itraconazole—Fatigue—Dexamethasone—psoriasis	2.5e-05	0.000268	CcSEcCtD
Itraconazole—Fatigue—Betamethasone—psoriasis	2.5e-05	0.000268	CcSEcCtD
Itraconazole—Shock—Prednisone—psoriasis	2.49e-05	0.000266	CcSEcCtD
Itraconazole—Pain—Dexamethasone—psoriasis	2.48e-05	0.000266	CcSEcCtD
Itraconazole—Pain—Betamethasone—psoriasis	2.48e-05	0.000266	CcSEcCtD
Itraconazole—Nervous system disorder—Prednisone—psoriasis	2.48e-05	0.000266	CcSEcCtD
Itraconazole—Tachycardia—Prednisone—psoriasis	2.47e-05	0.000264	CcSEcCtD
Itraconazole—Dizziness—Mycophenolate mofetil—psoriasis	2.47e-05	0.000264	CcSEcCtD
Itraconazole—Skin disorder—Prednisone—psoriasis	2.46e-05	0.000263	CcSEcCtD
Itraconazole—Hyperhidrosis—Prednisone—psoriasis	2.44e-05	0.000262	CcSEcCtD
Itraconazole—CYP3A7—Metabolism—NDUFA5—psoriasis	2.44e-05	0.00139	CbGpPWpGaD
Itraconazole—Vision blurred—Methotrexate—psoriasis	2.44e-05	0.000261	CcSEcCtD
Itraconazole—Asthenia—Hydrocortisone—psoriasis	2.44e-05	0.000261	CcSEcCtD
Itraconazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.43e-05	0.00138	CbGpPWpGaD
Itraconazole—Vomiting—Cyclosporine—psoriasis	2.43e-05	0.00026	CcSEcCtD
Itraconazole—Rash—Cyclosporine—psoriasis	2.41e-05	0.000258	CcSEcCtD
Itraconazole—Anorexia—Prednisone—psoriasis	2.41e-05	0.000258	CcSEcCtD
Itraconazole—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	2.41e-05	0.00137	CbGpPWpGaD
Itraconazole—Dermatitis—Cyclosporine—psoriasis	2.41e-05	0.000258	CcSEcCtD
Itraconazole—Pruritus—Hydrocortisone—psoriasis	2.4e-05	0.000257	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—psoriasis	2.4e-05	0.000257	CcSEcCtD
Itraconazole—Headache—Cyclosporine—psoriasis	2.4e-05	0.000257	CcSEcCtD
Itraconazole—Feeling abnormal—Betamethasone—psoriasis	2.39e-05	0.000256	CcSEcCtD
Itraconazole—Feeling abnormal—Dexamethasone—psoriasis	2.39e-05	0.000256	CcSEcCtD
Itraconazole—Gastrointestinal pain—Betamethasone—psoriasis	2.37e-05	0.000254	CcSEcCtD
Itraconazole—Gastrointestinal pain—Dexamethasone—psoriasis	2.37e-05	0.000254	CcSEcCtD
Itraconazole—Vomiting—Mycophenolate mofetil—psoriasis	2.37e-05	0.000254	CcSEcCtD
Itraconazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	2.36e-05	0.00134	CbGpPWpGaD
Itraconazole—Hypersensitivity—Triamcinolone—psoriasis	2.36e-05	0.000252	CcSEcCtD
Itraconazole—Rash—Mycophenolate mofetil—psoriasis	2.35e-05	0.000252	CcSEcCtD
Itraconazole—Dermatitis—Mycophenolate mofetil—psoriasis	2.35e-05	0.000252	CcSEcCtD
Itraconazole—Headache—Mycophenolate mofetil—psoriasis	2.34e-05	0.00025	CcSEcCtD
Itraconazole—Malaise—Methotrexate—psoriasis	2.33e-05	0.00025	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—psoriasis	2.33e-05	0.000249	CcSEcCtD
Itraconazole—Diarrhoea—Hydrocortisone—psoriasis	2.33e-05	0.000249	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—psoriasis	2.32e-05	0.000248	CcSEcCtD
Itraconazole—Urticaria—Betamethasone—psoriasis	2.31e-05	0.000247	CcSEcCtD
Itraconazole—Urticaria—Dexamethasone—psoriasis	2.31e-05	0.000247	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Prednisone—psoriasis	2.3e-05	0.000247	CcSEcCtD
Itraconazole—Dizziness—Prednisolone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Asthenia—Triamcinolone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Abdominal pain—Dexamethasone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Body temperature increased—Dexamethasone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Body temperature increased—Betamethasone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Abdominal pain—Betamethasone—psoriasis	2.3e-05	0.000246	CcSEcCtD
Itraconazole—Insomnia—Prednisone—psoriasis	2.29e-05	0.000245	CcSEcCtD
Itraconazole—Nausea—Cyclosporine—psoriasis	2.27e-05	0.000243	CcSEcCtD
Itraconazole—Paraesthesia—Prednisone—psoriasis	2.27e-05	0.000243	CcSEcCtD
Itraconazole—CYP51A1—Metabolism—CARM1—psoriasis	2.27e-05	0.00129	CbGpPWpGaD
Itraconazole—Pruritus—Triamcinolone—psoriasis	2.26e-05	0.000242	CcSEcCtD
Itraconazole—Cough—Methotrexate—psoriasis	2.26e-05	0.000242	CcSEcCtD
Itraconazole—Dizziness—Hydrocortisone—psoriasis	2.25e-05	0.000241	CcSEcCtD
Itraconazole—Dyspepsia—Prednisone—psoriasis	2.23e-05	0.000238	CcSEcCtD
Itraconazole—Nausea—Mycophenolate mofetil—psoriasis	2.22e-05	0.000237	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—psoriasis	2.2e-05	0.000236	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—psoriasis	2.2e-05	0.000236	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—psoriasis	2.2e-05	0.000236	CcSEcCtD
Itraconazole—Decreased appetite—Prednisone—psoriasis	2.2e-05	0.000235	CcSEcCtD
Itraconazole—Rash—Prednisolone—psoriasis	2.19e-05	0.000235	CcSEcCtD
Itraconazole—Dermatitis—Prednisolone—psoriasis	2.19e-05	0.000235	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.19e-05	0.000234	CcSEcCtD
Itraconazole—Fatigue—Prednisone—psoriasis	2.18e-05	0.000233	CcSEcCtD
Itraconazole—Headache—Prednisolone—psoriasis	2.18e-05	0.000233	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—psoriasis	2.18e-05	0.000233	CcSEcCtD
Itraconazole—Constipation—Prednisone—psoriasis	2.16e-05	0.000232	CcSEcCtD
Itraconazole—Vomiting—Hydrocortisone—psoriasis	2.16e-05	0.000231	CcSEcCtD
Itraconazole—Rash—Hydrocortisone—psoriasis	2.14e-05	0.000229	CcSEcCtD
Itraconazole—Dermatitis—Hydrocortisone—psoriasis	2.14e-05	0.000229	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—psoriasis	2.13e-05	0.000228	CcSEcCtD
Itraconazole—Headache—Hydrocortisone—psoriasis	2.13e-05	0.000228	CcSEcCtD
Itraconazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.12e-05	0.0012	CbGpPWpGaD
Itraconazole—Dizziness—Triamcinolone—psoriasis	2.12e-05	0.000227	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—psoriasis	2.11e-05	0.000226	CcSEcCtD
Itraconazole—Infection—Methotrexate—psoriasis	2.1e-05	0.000225	CcSEcCtD
Itraconazole—Feeling abnormal—Prednisone—psoriasis	2.08e-05	0.000223	CcSEcCtD
Itraconazole—Asthenia—Betamethasone—psoriasis	2.08e-05	0.000223	CcSEcCtD
Itraconazole—Asthenia—Dexamethasone—psoriasis	2.08e-05	0.000223	CcSEcCtD
Itraconazole—CYP3A7—Metabolism—CYP2S1—psoriasis	2.08e-05	0.00118	CbGpPWpGaD
Itraconazole—Nervous system disorder—Methotrexate—psoriasis	2.07e-05	0.000222	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—psoriasis	2.07e-05	0.000222	CcSEcCtD
Itraconazole—Gastrointestinal pain—Prednisone—psoriasis	2.07e-05	0.000221	CcSEcCtD
Itraconazole—Nausea—Prednisolone—psoriasis	2.07e-05	0.000221	CcSEcCtD
Itraconazole—ABCB1—Allograft Rejection—IFNG—psoriasis	2.06e-05	0.00117	CbGpPWpGaD
Itraconazole—Pruritus—Betamethasone—psoriasis	2.05e-05	0.00022	CcSEcCtD
Itraconazole—Pruritus—Dexamethasone—psoriasis	2.05e-05	0.00022	CcSEcCtD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.05e-05	0.00117	CbGpPWpGaD
Itraconazole—Skin disorder—Methotrexate—psoriasis	2.05e-05	0.00022	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—psoriasis	2.04e-05	0.000219	CcSEcCtD
Itraconazole—Vomiting—Triamcinolone—psoriasis	2.03e-05	0.000218	CcSEcCtD
Itraconazole—Nausea—Hydrocortisone—psoriasis	2.02e-05	0.000216	CcSEcCtD
Itraconazole—Rash—Triamcinolone—psoriasis	2.02e-05	0.000216	CcSEcCtD
Itraconazole—Dermatitis—Triamcinolone—psoriasis	2.02e-05	0.000216	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—psoriasis	2.01e-05	0.000216	CcSEcCtD
Itraconazole—Urticaria—Prednisone—psoriasis	2.01e-05	0.000215	CcSEcCtD
Itraconazole—Headache—Triamcinolone—psoriasis	2e-05	0.000215	CcSEcCtD
Itraconazole—Abdominal pain—Prednisone—psoriasis	2e-05	0.000214	CcSEcCtD
Itraconazole—Body temperature increased—Prednisone—psoriasis	2e-05	0.000214	CcSEcCtD
Itraconazole—Diarrhoea—Betamethasone—psoriasis	1.99e-05	0.000213	CcSEcCtD
Itraconazole—Diarrhoea—Dexamethasone—psoriasis	1.99e-05	0.000213	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—psoriasis	1.97e-05	0.000211	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—psoriasis	1.93e-05	0.000206	CcSEcCtD
Itraconazole—Dizziness—Dexamethasone—psoriasis	1.92e-05	0.000206	CcSEcCtD
Itraconazole—Dizziness—Betamethasone—psoriasis	1.92e-05	0.000206	CcSEcCtD
Itraconazole—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.91e-05	0.00109	CbGpPWpGaD
Itraconazole—Insomnia—Methotrexate—psoriasis	1.91e-05	0.000205	CcSEcCtD
Itraconazole—Nausea—Triamcinolone—psoriasis	1.9e-05	0.000204	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—psoriasis	1.9e-05	0.000203	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—psoriasis	1.88e-05	0.000202	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—psoriasis	1.88e-05	0.000201	CcSEcCtD
Itraconazole—Hypersensitivity—Prednisone—psoriasis	1.86e-05	0.000199	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—psoriasis	1.86e-05	0.000199	CcSEcCtD
Itraconazole—Vomiting—Dexamethasone—psoriasis	1.85e-05	0.000198	CcSEcCtD
Itraconazole—Vomiting—Betamethasone—psoriasis	1.85e-05	0.000198	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—psoriasis	1.84e-05	0.000197	CcSEcCtD
Itraconazole—Rash—Betamethasone—psoriasis	1.83e-05	0.000196	CcSEcCtD
Itraconazole—Rash—Dexamethasone—psoriasis	1.83e-05	0.000196	CcSEcCtD
Itraconazole—Dermatitis—Dexamethasone—psoriasis	1.83e-05	0.000196	CcSEcCtD
Itraconazole—Dermatitis—Betamethasone—psoriasis	1.83e-05	0.000196	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—psoriasis	1.82e-05	0.000195	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—psoriasis	1.82e-05	0.000195	CcSEcCtD
Itraconazole—Headache—Dexamethasone—psoriasis	1.82e-05	0.000195	CcSEcCtD
Itraconazole—Headache—Betamethasone—psoriasis	1.82e-05	0.000195	CcSEcCtD
Itraconazole—Asthenia—Prednisone—psoriasis	1.81e-05	0.000194	CcSEcCtD
Itraconazole—Pain—Methotrexate—psoriasis	1.81e-05	0.000193	CcSEcCtD
Itraconazole—CYP2B6—Metabolism—NDUFA5—psoriasis	1.81e-05	0.00102	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.79e-05	0.00102	CbGpPWpGaD
Itraconazole—Pruritus—Prednisone—psoriasis	1.79e-05	0.000192	CcSEcCtD
Itraconazole—CYP2E1—Metabolism—NDUFA5—psoriasis	1.77e-05	0.001	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—NDUFA5—psoriasis	1.76e-05	0.001	CbGpPWpGaD
Itraconazole—Feeling abnormal—Methotrexate—psoriasis	1.74e-05	0.000186	CcSEcCtD
Itraconazole—Diarrhoea—Prednisone—psoriasis	1.73e-05	0.000185	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—psoriasis	1.73e-05	0.000185	CcSEcCtD
Itraconazole—Nausea—Dexamethasone—psoriasis	1.72e-05	0.000185	CcSEcCtD
Itraconazole—Nausea—Betamethasone—psoriasis	1.72e-05	0.000185	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—psoriasis	1.68e-05	0.00018	CcSEcCtD
Itraconazole—Dizziness—Prednisone—psoriasis	1.67e-05	0.000179	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—psoriasis	1.67e-05	0.000179	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—psoriasis	1.67e-05	0.000179	CcSEcCtD
Itraconazole—CYP1A1—Metabolism—NDUFA5—psoriasis	1.67e-05	0.000946	CbGpPWpGaD
Itraconazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.62e-05	0.000922	CbGpPWpGaD
Itraconazole—Vomiting—Prednisone—psoriasis	1.61e-05	0.000172	CcSEcCtD
Itraconazole—Rash—Prednisone—psoriasis	1.59e-05	0.000171	CcSEcCtD
Itraconazole—Dermatitis—Prednisone—psoriasis	1.59e-05	0.000171	CcSEcCtD
Itraconazole—Headache—Prednisone—psoriasis	1.58e-05	0.00017	CcSEcCtD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.58e-05	0.000894	CbGpPWpGaD
Itraconazole—Hypersensitivity—Methotrexate—psoriasis	1.56e-05	0.000167	CcSEcCtD
Itraconazole—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.55e-05	0.000882	CbGpPWpGaD
Itraconazole—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.55e-05	0.000882	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—CYP2S1—psoriasis	1.53e-05	0.000871	CbGpPWpGaD
Itraconazole—Asthenia—Methotrexate—psoriasis	1.52e-05	0.000162	CcSEcCtD
Itraconazole—CYP2E1—Metabolism—CYP2S1—psoriasis	1.5e-05	0.000853	CbGpPWpGaD
Itraconazole—Nausea—Prednisone—psoriasis	1.5e-05	0.000161	CcSEcCtD
Itraconazole—CYP3A5—Metabolism—CYP2S1—psoriasis	1.5e-05	0.000851	CbGpPWpGaD
Itraconazole—Pruritus—Methotrexate—psoriasis	1.49e-05	0.00016	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—psoriasis	1.45e-05	0.000155	CcSEcCtD
Itraconazole—CYP1A1—Metabolism—CYP2S1—psoriasis	1.42e-05	0.000804	CbGpPWpGaD
Itraconazole—Dizziness—Methotrexate—psoriasis	1.4e-05	0.00015	CcSEcCtD
Itraconazole—CYP51A1—Metabolism—CAT—psoriasis	1.39e-05	0.000791	CbGpPWpGaD
Itraconazole—Vomiting—Methotrexate—psoriasis	1.34e-05	0.000144	CcSEcCtD
Itraconazole—Rash—Methotrexate—psoriasis	1.33e-05	0.000143	CcSEcCtD
Itraconazole—ABCB1—Allograft Rejection—TNF—psoriasis	1.33e-05	0.000756	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—NDUFA5—psoriasis	1.33e-05	0.000755	CbGpPWpGaD
Itraconazole—Dermatitis—Methotrexate—psoriasis	1.33e-05	0.000143	CcSEcCtD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.32e-05	0.000751	CbGpPWpGaD
Itraconazole—Headache—Methotrexate—psoriasis	1.32e-05	0.000142	CcSEcCtD
Itraconazole—Nausea—Methotrexate—psoriasis	1.26e-05	0.000134	CcSEcCtD
Itraconazole—CYP2D6—Metabolism—NDUFA5—psoriasis	1.25e-05	0.000712	CbGpPWpGaD
Itraconazole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.24e-05	0.000702	CbGpPWpGaD
Itraconazole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.18e-05	0.00067	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—CYP2S1—psoriasis	1.13e-05	0.000642	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—APOE—psoriasis	1.08e-05	0.000614	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—CYP2S1—psoriasis	1.07e-05	0.000605	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—CARM1—psoriasis	1.01e-05	0.000575	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—PPARG—psoriasis	9.43e-06	0.000535	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.78e-06	0.000498	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.45e-06	0.000479	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—NDUFA5—psoriasis	8.2e-06	0.000465	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.67e-06	0.000435	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—CARM1—psoriasis	7.5e-06	0.000425	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.43e-06	0.000421	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—CARM1—psoriasis	7.34e-06	0.000417	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—CARM1—psoriasis	7.33e-06	0.000416	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—CYP2S1—psoriasis	6.98e-06	0.000396	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—CARM1—psoriasis	6.92e-06	0.000393	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.57e-06	0.000373	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.47e-06	0.000367	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—CAT—psoriasis	6.23e-06	0.000354	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.79e-06	0.000329	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—CARM1—psoriasis	5.53e-06	0.000314	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—CARM1—psoriasis	5.21e-06	0.000296	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—APOE—psoriasis	4.84e-06	0.000275	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—CAT—psoriasis	4.61e-06	0.000262	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—CAT—psoriasis	4.52e-06	0.000256	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—CAT—psoriasis	4.51e-06	0.000256	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—CAT—psoriasis	4.26e-06	0.000242	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—PPARG—psoriasis	4.22e-06	0.000239	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—APOE—psoriasis	3.58e-06	0.000203	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—APOE—psoriasis	3.51e-06	0.000199	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—APOE—psoriasis	3.5e-06	0.000199	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—CARM1—psoriasis	3.41e-06	0.000193	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—CAT—psoriasis	3.4e-06	0.000193	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—APOE—psoriasis	3.31e-06	0.000188	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—CAT—psoriasis	3.2e-06	0.000182	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—PPARG—psoriasis	3.12e-06	0.000177	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—PPARG—psoriasis	3.06e-06	0.000173	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—PPARG—psoriasis	3.05e-06	0.000173	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—PPARG—psoriasis	2.88e-06	0.000163	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—APOE—psoriasis	2.64e-06	0.00015	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—APOE—psoriasis	2.49e-06	0.000141	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—PPARG—psoriasis	2.3e-06	0.000131	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—PPARG—psoriasis	2.17e-06	0.000123	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—CAT—psoriasis	2.1e-06	0.000119	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—APOE—psoriasis	1.63e-06	9.24e-05	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—PPARG—psoriasis	1.42e-06	8.05e-05	CbGpPWpGaD
